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ou probably weren’t thinking 
about your body’s DNA repair 
systems the last time you sat 
on the beach in the bright sunshine. 
Fortunately, however, while you were 
subjecting your DNA to the harmful 
effects of ultraviolet (UV) light, your 
cells were busy repairing the damage. 
The idea that our genetic material 
could be damaged by the sun was 
not appreciated in the early days of 
molecular biology. When Watson and 
Crick discovered the structure of DNA 
in 1953 [1], it was assumed that DNA 
is fundamentally stable since it carries 
the blueprint of life. However, more 
than 50 years of research have revealed 
that our DNA is under constant assault 
by sunlight, oxygen, radiation, various 
chemicals, and even our own cellular 
processes. Cleverly, evolution has 
provided our cells with a diverse set of 
tools to repair the damage that Mother 
Nature causes.
DNA repair processes restore the 
normal nucleotide sequence and 
DNA structure after damage [2]. 
These responses are highly varied 
and exquisitely regulated. DNA 
repair mechanisms are traditionally 
characterized by the type of damage 
repaired. A large variety of chemical 
modiﬁ  cations can alter normal DNA 
bases and either lead to mutations or 
block transcription if not repaired, and 
three distinct pathways exist to remove base damage. Base 
excision repair (BER) corrects DNA base alterations that do 
not distort the overall structure of the DNA helix, such as 
bases damaged by oxidation resulting from normal cellular 
metabolism. While BER removes single damaged bases, 
nucleotide excision repair (NER) removes short segments of 
nucleotides (called oligonucleotides) containing damaged 
bases. NER responds to any alteration that distorts the 
DNA helix and is the mechanism responsible for repairing 
bulky base damage caused by carcinogenic chemicals 
such as benzo [a]pyrene (found in cigarette smoke and 
automobile exhaust) as well as covalent linkages between 
adjacent pyrimidine bases resulting from the UV component 
of sunlight. NER can be divided into two classes based on 
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Figure 1. Nucleotide Excision Repair Schematic
When DNA is damaged by sunlight, the damage is recognized differently depending on whether 
the DNA is transcriptionally active (transcription-coupled repair) or not (global excision repair). 
After the initial recognition step, the damage is repaired in a similar manner with the ﬁ  nal outcome 
being the restoration of the normal nucleotide sequence. A more detailed description is provided 
in the text.PLoS Biology  |  www.plosbiology.org 0900
where the repair occurs. NER occurring in DNA that is 
not undergoing transcription (i.e., most of the genome) is 
called global genome repair (GG-NER or GGR), while NER 
taking place in the transcribed strand of active genes is called 
transcription-coupled repair (TCR or TC-NER). We will 
explore NER in more detail below. Mismatch repair (MMR) 
is another type of excision repair that speciﬁ  cally removes 
mispaired bases resulting from replication errors. 
DNA damage can also result in breaks in the DNA 
backbone, in one or both strands. Single-strand breaks are 
efﬁ  ciently repaired by a mechanism that shares common 
features with the later steps in BER. Double-strand breaks 
(DSBs) are especially devastating, since by deﬁ  nition there 
is no intact complementary strand to serve as a template for 
repair, and even one unrepaired DSB can be lethal [3]. In 
cells that have replicated their DNA prior to cell division, 
the missing information can be supplied by the duplicate 
copy, or sister chromatid, and DSBs in these cells are 
faithfully repaired by homologous recombination involving 
the exchange of strands of DNA between the two copies. 
However, most cells in the body are non-dividing, and in 
these cells the major mechanism for repairing DSBs is by non-
homologous end joining (NHEJ), which, as the name implies, 
involves joining two broken DNA ends without a requirement 
for homologous sequence and which, therefore, has a high 
potential for loss of genetic information. 
Hereditary defects in DNA repair. The biological 
consequences of defects or deﬁ  ciencies in DNA repair are 
varied and often severe. Mutations in genes that encode 
DNA repair proteins cause a wide variety of rare inherited 
human syndromes that exhibit diverse clinical phenotypes. 
Most include a premature aging phenotype, either 
photosensitivity or increased sensitivity to ionizing radiation 
exposure, greatly increased cancer risk, or all three. Nearly 
all hereditary DNA repair diseases are recessive, meaning 
that both copies of a gene must be mutated in order for the 
disease to develop. As a result, these diseases are extremely 
rare, collectively accounting for less than 5% of all human 
cancers [2]. The vast majority of human cancers are 
spontaneous (not inherited) and result from a combination 
of genetic and environmental contributions. Identifying 
genetic variations in the normal population that increase 
risk of cancer is of considerable public health interest, and 
DNA repair genes are likely candidates. Elucidating the 
molecular mechanisms that underlie inherited defects in 
DNA repair will provide a framework for understanding the 
complex patterns of predisposing genetic variations that 
will surely emerge from large-scale studies of spontaneous 
human cancers. 
Diseases have been linked with defects in all types of DNA 
repair pathways. For example, hereditary nonpolyposis colon 
cancer results from defects in mismatch repair genes, and 
hereditary breast cancer is caused by mutations affecting the 
breast cancer-associated proteins BRCA1 or BRCA2 that play 
a role in DSB repair by homologous recombination. Here 
we describe in more detail the devastating human disorders 
known to be caused by defects in NER (Table 1).
Xeroderma pigmentosum (XP). Although rare, XP is the 
most common of the DNA repair defective diseases and 
the most well known. In the United States the frequency of 
XP is approximately 1 case per 250,000, and in Japan the 
frequency is much higher, at 1:40,000 [4]. The discovery of 
26 XP children in one small mountain village in Guatemala 
[5] focused recent international attention on XP, but it was 
ﬁ  rst described in 1874 [6] and was ﬁ  rst shown to be caused 
by defects in NER in the late 1960s [7]. The most evident 
clinical features of XP are extreme sun sensitivity with marked 
thickening of the skin (“xeroderma”), together with changes 
in pigmentation (“pigmentosum”) and a very high incidence 
of skin cancers on sun-exposed regions of the body. Eye and 
neurological abnormalities are also common. XP patients 
can be subdivided into eight complementation groups, XP-
A through -G plus XP-V, based on which gene is affected. 
Seven of the eight genes (XPA through XPG) are directly 
involved in NER, while the XPV (variant) gene product is a 
DNA polymerase that is involved in DNA replication past UV 
lesions (“translesion synthesis”). 
Cockayne syndrome (CS). First described by Edward 
Cockayne in the 1930s [8], CS is a developmental disorder 
involving profound mental retardation, premature aging, 
and severe wasting that become evident within the ﬁ  rst few 
years of life and lead to death in childhood. CS patients are 
also sun-sensitive, but unlike XP patients, do not develop 
skin cancers. CS most frequently arises from mutations in 
genes encoding the CSA and CSB proteins. Both proteins are 
required for TCR, suggesting that defective repair of lesions 
in active DNA may be causative for the disease. However, 
the exact cellular function of the CSB protein has not yet 
been determined, and the nature of its causative role in CS is 
further complicated by the surprising ﬁ  nding that a patient 
diagnosed with UV-sensitive syndrome, an extremely mild 
sun-sensitive disease without any of the severe clinical features 
of CS, completely lacks any CSB protein [9]. In rare cases, 
certain mutations in the XPB, XPD, and XPG genes lead to 
XP combined with CS. These XP/CS patients are profoundly 
affected, having clinical features of both disorders.
Trichothiodystrophy (TTD). This syndrome is 
characterized by sulfur (“thio”)-deﬁ  cient brittle hair 
Table 1. Human Diseases Caused by Defects in Nucleotide Excision Repair
Human Disease Genes Clinical Features Molecular Defect
Xeroderma pigmentosum (XP) XPA–XPG; XPV Sun sensitivity; cancer; neurological defects Nucleotide excision repair (NER); translesion 
synthesis
Cockayne syndrome (CS) CSA; CSB Sun sensitivity; post-natal developmental defects; 
neurological defects; premature aging
Transcription-coupled repair (TCR)
XP/CS XPB; XPD; XPG Both XP and CS Both global and transcription-coupled NER
Photosensitive 
trichothiodystrophy (TTD) 
XPB; XPD; TTDA Sun sensitivity; post-natal developmental defects; 
premature aging; brittle hair; scaly skin
NER; transcription
UV-sensitive syndrome (UVsS) CSB; unknown gene(s) Sun sensitivity Transcription-coupled repair
DOI: 10.1371/journal.pbio.0040203.t001
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(“tricho”) with malformed (“dystrophy”) hair shafts, ﬁ  sh-
like scales on the skin, mental and physical retardation, 
and sun sensitivity in some complementation groups [10]. 
Mutations in the XPD and XPB genes have been found 
to cause the sun-sensitive form of TTD [11,12], but, until 
recently, the molecular basis for a third sun-sensitive TTD 
complementation group, TTD-A, was unknown. In 2004 
the gene mutated in TTD-A was identiﬁ  ed and shown to 
encode a tiny protein of only 71 amino acids (8 kDa) [13]. 
Remarkably, the small TTDA protein is the tenth subunit 
of a key multi-protein complex called TFIIH that was ﬁ  rst 
described as a transcription factor essential for transcription 
initiation by RNA polymerase II (RNAPII) [14] and was 
later found to be required for NER as well [15]. The XPB 
and XPD proteins are also components of TFIIH, making it 
clear that compromised TFIIH deﬁ  nes the molecular basis 
for the sun-sensitive form of TTD. 
Nucleotide excision repair. Much of our understanding of 
NER in humans has come from studies of cells from XP and 
CS patients. NER (shown schematically in Figure 1) can be 
generally broken down into ﬁ  ve steps: damage recognition 
to initiate repair, helix opening and unwinding, incision on 
either side of the lesion, excision (release) of the damage-
containing oligonucleotide, and DNA synthesis and ligation. 
GG-NER and TCR differ in how damage is recognized 
and also in biological outcome. GG-NER protects against 
mutations in the genome from replication of unrepaired 
lesions that could ultimately lead to cancer, while TCR 
ensures that genes are transcribed correctly and efﬁ  ciently, 
a function that is now appreciated to be important in 
protecting against aging [16].
The NER machinery responds when DNA suffers damage 
that distorts its helical structure. DNA lesions caused by UV 
are the best example of this type of damage and have been 
extensively studied, since they are easy to generate in the 
lab, are stable in DNA, and are biologically important for 
any organism that is exposed to sunlight. Repair is initiated 
when the helix distortion is recognized by the XPC protein 
together with its partner hHR23B. Some less distorting 
lesions ﬁ  rst require initial recognition by the DDB complex, 
which is mutated in XP-E cells. The TFIIH complex is then 
recruited by XPC and is immediately joined by the XPA 
protein, the single-stranded DNA binding protein RPA, and 
the XPG protein. The XPB and XPD components of TFIIH 
are DNA helicases (named for ability to disrupt the double 
helix), and through their action TFIIH unwinds the DNA 
surrounding the lesion until a 30-nucleotide “bubble” is 
formed. RPA and XPA stabilize the DNA bubble and also 
help to position two endonucleases at the bubble junctions, 
where they serve as “scissors” to cut out the DNA damage. 
The ﬁ  rst incision, on the 3′ side of the bubble relative to the 
lesion, is made by XPG, which also coordinates the second 
incision on the 5′ side of the bubble by the XPF protein 
and its partner ERCC1 [17,18]. A lesion-containing DNA 
fragment of 25–32 nucleotides is released, the gap is ﬁ  lled in 
by a DNA polymerase using the information from the intact 
complementary strand, and the remaining nick is sealed by a 
DNA ligase that restores the intact strand.
A major decision point in NER concerns how the enzymatic 
machinery “knows” which of the two DNA strands should 
be cleaved, or indeed whether cleavage should occur at all 
(which is appropriate only if a lesion is actually present). 
Presumably some mechanism for lesion veriﬁ  cation must be 
involved. The damage-binding protein XPA is likely to play 
a role, since it is essential for NER incisions. However, as 
described below, new evidence suggests the possibility that 
the multi-functional TFIIH complex is also involved.
Transcription-coupled repair. DNA that is undergoing 
transcription initiates NER in a different manner (Figure 1), 
since UV lesions directly block elongating RNAPII [19,20]. 
The original and still current model for TCR [21] postulates 
that RNAP blocked by a lesion in the DNA template is more 
efﬁ  ciently recognized than the lesion itself, providing a 
potent signal for recruiting repair enzymes. This idea nicely 
explains how TCR occurs much more rapidly than GG-NER 
[21]. Consistent with different recognition signals, the 
XPC/hHR23B protein complex is not required for TCR 
[22,23], and instead the CSB protein has been implicated in 
initiation of TCR through recognition of stalled RNAP [24], 
probably in concert with XPG [25]. After the recognition 
step, however, it is not clear how the recruited DNA repair 
proteins gain access to the DNA lesion, since it is occluded 
by the stalled polymerase [26]. Backup of RNAP facilitated 
by the transcription elongation factor TFIIS is one proposed 
mechanism for removing the polymerase from the lesion 
[27]; however, CSB actually appears to prevent TFIIS 
action [28,29], and hence backup may be an alternative 
to TCR. Degradation of the arrested RNAP has also been 
proposed, but this is likely to be a last resort when TCR fails, 
rather than part of the mechanism [30]. Recent evidence 
suggests that TFIIH in the presence of XPG may function 
to remodel RNAPII in an ATP-dependent manner during 
TCR through large-scale conformational changes that allow 
access to the lesion without removal of the polymerase [25]. 
In any case, the subsequent steps of TCR evidently proceed 
in a manner similar to GG-NER, with the ﬁ  nal outcome 
being the efﬁ  cient generation of a lesion-free template for 
transcription.
DOI: 10.1371/journal.pbio.0040203.g002
Figure 2. TFIIH Is a Multi-Functional Protein Complex
TFIIH participates in normal transcription, NER, and TCR and has multiple 
functions in each of these processes. A medium-resolution electron 
microscopy structure of the human TFIIH complex [36] shows that TFIIH 
forms a ring-like structure with a protrusion that contains the CAK kinase 
complex.
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TFIIH in transcription. In addition to TCR, transcription 
and NER are linked by the separate involvement of TFIIH in 
both processes. In transcription initiation, TFIIH is required 
for unwinding the DNA helix at the transcription start site, 
and XPB is essential for this process. TFIIH also has kinase 
activity provided by its CAK kinase three-protein subunit, 
which phosphorylates the carboxyl-terminal domain (CTD) of 
RNAPII. CTD phosphorylation is required for the polymerase 
to escape the promoter and begin elongating the transcript. 
How TFIIH is shared between NER and transcription is an 
open question. Innovative imaging techniques have begun 
to answer this question by probing the dynamics of TFIIH in 
living cells.
Cellular dynamics of DNA repair. Live-cell imaging is a 
powerful technique to probe the cellular responses of the 
NER machinery to DNA damage, and it has been used to 
demonstrate that the NER proteins do not appear to exist 
in a pre-assembled complex but rather assemble in an 
ordered fashion at sites of DNA damage [31]. In particular, 
the dynamic movements of the multi-functional TFIIH have 
been monitored in living cells by linking a TFIIH subunit 
to the green ﬂ  uorescent protein (GFP) from jellyﬁ  sh. After 
photo-bleaching a portion of the cell’s nucleus with a laser, 
a population of ﬂ  uorescently labeled proteins can be seen 
moving back into the bleached area over time, and the speed 
at which this repopulation takes place can be measured. 
Hoogstraten et al (2002) used live-cell imaging of GFP-labeled 
XPB to examine the crosstalk of TFIIH between transcription 
and repair and showed that TFIIH migrates freely in the 
nucleus, functioning in repair or transcription with different 
kinetics [32]. TFIIH molecules interact longer with NER sites 
than with transcription sites (5 minutes versus 10 seconds). 
This simple observation provided signiﬁ  cant insight into the 
origin of TTD phenotypes. TTD-A cells were known to have 
low levels of TFIIH, but TFIIH isolated from these cells had 
normal in vitro enzymatic activities, suggesting that TFIIH 
stability rather than function might be compromised, and 
indeed the TTDA protein increases TFIIH stability [13]. The 
live-cell imaging result provided a framework to interpret 
this observation. Since TFIIH molecules are recycled much 
more rapidly during transcription than during NER, higher 
concentrations of TFIIH are required to efﬁ  ciently carry out 
NER. Thus low levels of TFIIH have a more dramatic effect 
on NER than on transcription and would cause an apparent 
defect in transcription only in terminally differentiated tissues 
with high transcriptional loads such as hair and skin, which is 
what is observed in TTD patients. 
In this issue of PLoS Biology, Giglia-Mari et al. used live-cell 
imaging to explore the dynamic movements of TTDA and 
XPD [33]. TTDA (and XPD to a lesser extent) was shown 
to be present in two populations that move with different 
dynamics: one population was stably associated with TFIIH 
(slow moving), while the other population moved freely 
around the cell (fast moving), even shuttling between the 
nucleus and the cytoplasm. After UV irradiation, more of the 
TTDA was found to be slow moving, suggesting that TTDA 
particularly remains associated with TFIIH during NER. The 
authors established that in fact TTDA stably associates with 
TFIIH only during productive NER events by using a clever 
trick. They treated the cells with actinomycin D (ActD), a 
chemical that inserts into DNA and then damages it when 
exposed to blue light but that is not repaired by NER. The 
initial responders in NER, XPC, and TFIIH (monitored 
with XPB-GFP), were recruited to the ActD lesions, but not 
TTDA or the later NER factors, XPA or ERCC1. TTDA was 
not fooled by the ActD lesions, suggesting that TFIIH—and 
possibly TTDA itself—plays a role in lesion veriﬁ  cation and 
the recruitment of subsequent NER factors. Two other recent 
observations also suggest involvement of TFIIH in lesion 
veriﬁ  cation, perhaps involving XPB and/or XPD. The altered 
TFIIH in cells from XP-D/CS patients results in aberrant 
production of incisions at sites of transcription rather than at 
DNA lesions [34], and a recent crystallographic structure of 
an XPB homolog has revealed the surprising existence of a 
domain that recognizes damaged DNA [35].
Perspectives. The TFIIH complex sits at the crossroads 
of GG-NER, transcription, and TCR (Figure 2). It has two 
distinct functions in initiation of transcription and a still-
expanding number of different functions in NER, certainly 
including opening of the helix to allow incision but perhaps 
also including lesion veriﬁ  cation and even remodeling of 
the RNAP in TCR. Different defects in its multiple functions 
cause three different human syndromes: XP, XP/CS, 
and TTD. Determining the precise mechanisms of each 
of these functions will require high-resolution structural 
information of TFIIH components and complexes, coupled 
with innovative biological experiments such as those that 
probe the dynamic movements of TFIIH within the cell. Such 
future investigations will provide further key insights into 
the molecular basis of human repair deﬁ  ciency diseases that 
result in cancer predisposition and premature aging.  
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